[
  {
    "ts": null,
    "headline": "PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co",
    "summary": "Insights from the First Quarter of 2025",
    "url": "https://finnhub.io/api/news?id=0bd7565a5f55671a794bda4cdee293b4c4d9851144e755ef2af095c4ba8b0bee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746831985,
      "headline": "PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co",
      "id": 134362229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Insights from the First Quarter of 2025",
      "url": "https://finnhub.io/api/news?id=0bd7565a5f55671a794bda4cdee293b4c4d9851144e755ef2af095c4ba8b0bee"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Worries Shift to Prices From Trade. Trump’s Next Plan Could Sink Stocks.",
    "summary": "Pharma Worries Shift to Prices From Trade. Trump’s Next Plan Could Sink Stocks.",
    "url": "https://finnhub.io/api/news?id=ac42ac8bc85d73493d6981014a986e53594cf61c1bfd01b8285a21aa7f5271a9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746809460,
      "headline": "Pharma Worries Shift to Prices From Trade. Trump’s Next Plan Could Sink Stocks.",
      "id": 134382841,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Pharma Worries Shift to Prices From Trade. Trump’s Next Plan Could Sink Stocks.",
      "url": "https://finnhub.io/api/news?id=ac42ac8bc85d73493d6981014a986e53594cf61c1bfd01b8285a21aa7f5271a9"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=aec180c8bac48034cc353ad9c29d548e5e5d37af68c3d63563d31b6980b16643",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746808260,
      "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "id": 134382842,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=aec180c8bac48034cc353ad9c29d548e5e5d37af68c3d63563d31b6980b16643"
    }
  },
  {
    "ts": null,
    "headline": "Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down",
    "summary": "NKTR incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year. Shares fall in after-hours trading.",
    "url": "https://finnhub.io/api/news?id=e8e12c404d7a7f29c4ce9d9fb051f3cf173a4fd7fc98fab2db2a38f96fab78a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746796080,
      "headline": "Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down",
      "id": 134362231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "NKTR incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year. Shares fall in after-hours trading.",
      "url": "https://finnhub.io/api/news?id=e8e12c404d7a7f29c4ce9d9fb051f3cf173a4fd7fc98fab2db2a38f96fab78a8"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Brings the Bitcoin-Versus-Gold Clash to ETF Masses",
    "summary": "(Bloomberg) -- The culture clash between Bitcoin enthusiasts and gold bugs is about to be played out in the world of exchange-traded funds.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Tidal Fina",
    "url": "https://finnhub.io/api/news?id=0de56a884226be23500142a0966d2f45f9b423ab9fa84607d1a1dd3375cfae73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746793094,
      "headline": "Wall Street Brings the Bitcoin-Versus-Gold Clash to ETF Masses",
      "id": 134362206,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- The culture clash between Bitcoin enthusiasts and gold bugs is about to be played out in the world of exchange-traded funds.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Tidal Fina",
      "url": "https://finnhub.io/api/news?id=0de56a884226be23500142a0966d2f45f9b423ab9fa84607d1a1dd3375cfae73"
    }
  },
  {
    "ts": null,
    "headline": "Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation",
    "summary": "Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next eight years. This partnership, which has the potential to be the largest ever industry-academic agreement of its kind in the United States, will seek to accelerate innovation at every stage of the pharmaceutical pipeline.",
    "url": "https://finnhub.io/api/news?id=07f8ff1e8cacf5378c481127fcf58a333cee0ee09dea955eff980df97f8ebf36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746792000,
      "headline": "Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation",
      "id": 134362234,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next eight years. This partnership, which has the potential to be the largest ever industry-academic agreement of its kind in the United States, will seek to accelerate innovation at every stage of the pharmaceutical pipeline.",
      "url": "https://finnhub.io/api/news?id=07f8ff1e8cacf5378c481127fcf58a333cee0ee09dea955eff980df97f8ebf36"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk: It's Not Been This Cheap For Many Years",
    "summary": "Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why NVO stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=2fad8a155db2a87da645d6a9649d599044c32a70860addaac42adfd0ce4cd967",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746790200,
      "headline": "Novo Nordisk: It's Not Been This Cheap For Many Years",
      "id": 134345547,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158305431/image_2158305431.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why NVO stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=2fad8a155db2a87da645d6a9649d599044c32a70860addaac42adfd0ce4cd967"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly extends Purdue alliance; EMA investigates Valneva shot",
    "summary": "The big pharma will spend up to $250 million over the next eight years of the collaboration. Elsewhere, CRISPR Therapeutics unveiled new data and Vivo Capital raised funds.",
    "url": "https://finnhub.io/api/news?id=3636a3496052dba4f8b1f9601c234e0452d63eaf35dcfa60b623082ee7333064",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746788400,
      "headline": "Eli Lilly extends Purdue alliance; EMA investigates Valneva shot",
      "id": 134362235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The big pharma will spend up to $250 million over the next eight years of the collaboration. Elsewhere, CRISPR Therapeutics unveiled new data and Vivo Capital raised funds.",
      "url": "https://finnhub.io/api/news?id=3636a3496052dba4f8b1f9601c234e0452d63eaf35dcfa60b623082ee7333064"
    }
  },
  {
    "ts": null,
    "headline": "4 No-Brainer Stocks to Buy Right Now",
    "summary": "The current volatile situation shouldn't preclude investors from buying stocks.  Eli Lilly, Vertex, Meta Platforms, and Netflix all stand to enjoy solid growth.  Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time.",
    "url": "https://finnhub.io/api/news?id=a5f5c6b1d757b5921fd582c265884aec020450fa897231e4ecd771e644560f9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746786600,
      "headline": "4 No-Brainer Stocks to Buy Right Now",
      "id": 134335710,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The current volatile situation shouldn't preclude investors from buying stocks.  Eli Lilly, Vertex, Meta Platforms, and Netflix all stand to enjoy solid growth.  Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time.",
      "url": "https://finnhub.io/api/news?id=a5f5c6b1d757b5921fd582c265884aec020450fa897231e4ecd771e644560f9e"
    }
  },
  {
    "ts": null,
    "headline": "Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise",
    "summary": "Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR stock is a hold.",
    "url": "https://finnhub.io/api/news?id=16bd0da0636aa05b8bfc8d862e8e00507956eb69509248df4b1e2fa91624563d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746783058,
      "headline": "Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise",
      "id": 134339290,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189405678/image_2189405678.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR stock is a hold.",
      "url": "https://finnhub.io/api/news?id=16bd0da0636aa05b8bfc8d862e8e00507956eb69509248df4b1e2fa91624563d"
    }
  },
  {
    "ts": null,
    "headline": "Haya secures $65m in Series A funds to advance heart failure treatment",
    "summary": "The funding round was spearheaded by Earlybird Venture Capital and Sofinnova Partners.",
    "url": "https://finnhub.io/api/news?id=973875202c5a0b72f19c81e0351afeb4af5467f70e46b9027223c117e1478409",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746782774,
      "headline": "Haya secures $65m in Series A funds to advance heart failure treatment",
      "id": 134335776,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The funding round was spearheaded by Earlybird Venture Capital and Sofinnova Partners.",
      "url": "https://finnhub.io/api/news?id=973875202c5a0b72f19c81e0351afeb4af5467f70e46b9027223c117e1478409"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Expands Purdue University Collaboration With Up To $250 Million Investment Over Next 8 Years",
    "summary": "Eli Lilly and Co: * ELI LILLY: EXPANDS PURDUE UNIVERSITY COLLABORATION WITH UPTO$250 MILLION INVESTMENT OVER NEXT 8 YEARS * ELI LILLY: EARLIER AGREEMENT WITH PURDUE...",
    "url": "https://finnhub.io/api/news?id=ddb2d5fa0dc3ed948b1ca8b7efffdd4c79d8a2de7aac1191a9bc3367aca551bd",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746777966,
      "headline": "Eli Lilly Expands Purdue University Collaboration With Up To $250 Million Investment Over Next 8 Years",
      "id": 134336851,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly and Co: * ELI LILLY: EXPANDS PURDUE UNIVERSITY COLLABORATION WITH UPTO$250 MILLION INVESTMENT OVER NEXT 8 YEARS * ELI LILLY: EARLIER AGREEMENT WITH PURDUE...",
      "url": "https://finnhub.io/api/news?id=ddb2d5fa0dc3ed948b1ca8b7efffdd4c79d8a2de7aac1191a9bc3367aca551bd"
    }
  }
]